Sanofi (SNY) Change in Cash (2014 - 2026)

Sanofi has reported Change in Cash for 10 years, with the latest figure at $929.9 million in Q2 2026.

• Quarterly Change in Cash fell 88.85% year-over-year to $929.9 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $10.4 billion (down 43.04% YoY) and the FY2025 annual result came in at $251.4 million, up 118.54% from the prior year.
• Change in Cash advanced to $929.9 million in Q2 2026 per SNY's latest filing, from -$2.5 billion in the prior quarter.
• Over five years, Change in Cash peaked at $12.2 billion in Q3 2023 and troughed at -$14.1 billion in Q2 2022.
• A 5-year average of $2.8 billion and a median of $1.7 billion in 2025 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2025 and 2026: Change in Cash jumped 853.0% in 2025, then plunged 527.59% in 2026.
• Over 5 years, Change in Cash stood at $10.2 billion in 2022, then plunged by 32.0% to $6.9 billion in 2023, then plunged by 119.58% to -$1.4 billion in 2024, then surged by 853.0% to $10.2 billion in 2025, then tumbled by 90.89% to $929.9 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered $929.9 million, -$2.5 billion, and $10.2 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.